Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.AEZS
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:AEZS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 08, 2024 6:10am
RE:RE:RE:Avenanthramide and VCAM-1
Avenanthramides have demonstrated promising anti-inflammatory and antioxidant effects that could potentially benefit cardiovascular health and wound healing. Here are some key points: Reducing
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 07, 2024 11:52pm
RE:RE:Avenanthramide and VCAM-1
Based on the provided search results, avenanthramides offer several potential benefits beyond lowering VCAM-1 for treating cardiovascular disease: Anti-inflammatory Effects Avenanthramides inhibit
...more
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource
posted Sep 19, 2024 9:00am by
Northstar Gold Corp.
-
|
The MOU grants Hunan Nonferrous the opportunity to explore and develop a near-surface NI43-101 gold mineral resource at Northstar’s 100%-owned Miller Copper-Gold Property, located 18 kilometers southeast of Kirkland Lake, Ontario. This will be achieved by diamond drilling up to 10,000 meters, allowing Hunan Nonferrous to earn a negotiated interest in the resultant NI43-101 gold resource. ...read more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 07, 2024 10:46pm
RE:Avenanthramide and VCAM-1
Based on the provided search results, it is difficult to make a definitive comparison of the safety/tolerability profile of avenanthramide at different doses (30mg, 120mg, 240mg, 480mg twice daily
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 07, 2024 10:15pm
Avenanthramide and VCAM-1
Perplexity Ai: "Based on the provided search results, there are currently no approved drugs that directly target vascular cell adhesion molecule-1 (VCAM-1) for therapeutic purposes. However
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 07, 2024 4:34pm
Poem
I asked Perplexity Ai to write a poem about where we are now as Ceapro gets on the world's largest biotech stage with the marriage to Aeterna Zentaris and what the next twelve months promise
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 07, 2024 4:18pm
Historical stock moves
Perplexity Ai: "Major stock price movements mentioned include a 66% surge after Macrilen received marketing approval."
(167)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Post by
Hopeforthebest
on Jun 07, 2024 4:04pm
RE:Proph what happened
Well I knew this was to good to be true, proph back to the garbage. I would rather have BNN promote a stock, taking Czo from a unknown penny stock to values well above $2. Whereas gagnon taking a
...more
(3)
•••
Schellaj
X
View Profile
View Bullboard History
Comment by
Schellaj
on Jun 07, 2024 3:50pm
RE:For CZO shareholders
BMO got back to me and said that the shares are set to switch over to AEZS for the 11th.
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 07, 2024 12:08pm
RE:Proph what happened
"AEZS is still every much a mystery until we see a plan, data, and key events." I've always said that we are ahead of the key defining events. That's what makes it interesting. You
...more
(167)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Post by
Hopeforthebest
on Jun 07, 2024 11:45am
Proph what happened
Proph after all the garbage postings and defending of gagnon and NoShowRonnie you has finally moved from the dark side to see the light as you wrote: AEZS has fallen from ~C$14 to ~C$10 as the
...more
(3)
•••
Schellaj
X
View Profile
View Bullboard History
Comment by
Schellaj
on Jun 07, 2024 9:49am
RE:For CZO shareholders
I'm in contact with BMO Investorline and they are currently looking into it. I will update when I have more info.
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 07, 2024 8:58am
For CZO shareholders
Schellaj wrote:My shares though BMO Investorline have yet to be switched over as well. No response from Ceapro either. Not a very comfortable situation right now. Some CZO shareholders
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 07, 2024 8:36am
RE:RE:New Press Release - Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders
It could have been written by an automated Ai program just fishing for business. The US has a lot of these investigation news releases flood a major even when the stock drops. AEZS has fallen from ~C
...more
(3)
•••
Schellaj
X
View Profile
View Bullboard History
Comment by
Schellaj
on Jun 07, 2024 7:18am
RE:New Press Release - Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders
Why does this article state the incorrect exchange rate for Ceapro to Aeterna shares?
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 07, 2024 3:18am
New Press Release - Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders
MILWAUKEE, June 7, 2024 /PRNewswire/ -- Ademi LLP is investigating Aeterna (Nasdaq: AEZS) for possible breaches of fiduciary duty and other violations of law in its transaction with Ceapro.Click here to learn how to join our investigation: https://www.ademilaw.com/case/aeterna-zentaris-inc or...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
EnviroGold Global Announces Appointment of Chief Operating Officer
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed